Value of Angiotensin receptor blocker therapy in diabetes.
about
Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction.What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.A review of the use of angiotensin receptor blockers for the prevention of cardiovascular events in patients with essential hypertension without compelling indications.
P2860
Value of Angiotensin receptor blocker therapy in diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Value of Angiotensin receptor blocker therapy in diabetes.
@en
Value of Angiotensin receptor blocker therapy in diabetes.
@nl
type
label
Value of Angiotensin receptor blocker therapy in diabetes.
@en
Value of Angiotensin receptor blocker therapy in diabetes.
@nl
prefLabel
Value of Angiotensin receptor blocker therapy in diabetes.
@en
Value of Angiotensin receptor blocker therapy in diabetes.
@nl
P2860
P1476
Value of Angiotensin receptor blocker therapy in diabetes.
@en
P2093
Adrienne S Zion
Joseph L Izzo
P2860
P304
P356
10.1111/J.1751-7176.2011.00447.X
P577
2011-04-01T00:00:00Z